Semiconductors
Compare Stocks
5 / 10Stock Comparison
TRT vs NVEC vs RELL vs LRCX vs AMAT
Revenue, margins, valuation, and 5-year total return — side by side.
Semiconductors
Hardware, Equipment & Parts
Semiconductors
Semiconductors
TRT vs NVEC vs RELL vs LRCX vs AMAT — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Semiconductors | Semiconductors | Hardware, Equipment & Parts | Semiconductors | Semiconductors |
| Market Cap | $101M | $429M | $183M | $357.66B | $325.54B |
| Revenue (TTM) | $49M | $26M | $213M | $21.68B | $28.37B |
| Net Income (TTM) | $-109K | $15M | $806K | $6.71B | $7.00B |
| Gross Margin | 19.7% | 78.7% | 31.1% | 50.0% | 48.7% |
| Operating Margin | 0.5% | 60.5% | 1.8% | 34.3% | 29.2% |
| Forward P/E | — | 18.9x | 58.3x | 50.7x | 37.1x |
| Total Debt | $2M | $740K | $2M | $4.76B | $6.55B |
| Cash & Equiv. | $11M | $2M | $36M | $6.39B | $7.24B |
TRT vs NVEC vs RELL vs LRCX vs AMAT — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Trio-Tech Internati… (TRT) | 100 | 408.5 | +308.5% |
| NVE Corporation (NVEC) | 100 | 146.4 | +46.4% |
| Richardson Electron… (RELL) | 100 | 353.8 | +253.8% |
| Lam Research Corpor… (LRCX) | 100 | 1046.4 | +946.4% |
| Applied Materials, … (AMAT) | 100 | 730.7 | +630.7% |
Price return only. Dividends and distributions are not included.
Quick Verdict: TRT vs NVEC vs RELL vs LRCX vs AMAT
Each card shows where this stock fits in a portfolio — not just who wins on paper.
TRT ranks third and is worth considering specifically for stability.
- Beta 0.52 vs LRCX's 2.54, lower leverage
NVEC carries the broadest edge in this set and is the clearest fit for income & stability and sleep-well-at-night.
- Dividend streak 2 yrs, beta 1.58, yield 4.5%
- Lower volatility, beta 1.58, Low D/E 1.3%, current ratio 28.21x
- Beta 1.58, yield 4.5%, current ratio 28.21x
- Lower P/E (18.9x vs 50.7x)
RELL lags the leaders in this set but could rank higher in a more targeted comparison.
LRCX is the #2 pick in this set and the best alternative if growth exposure and long-term compounding is your priority.
- Rev growth 23.7%, EPS growth 43.1%, 3Y rev CAGR 2.3%
- 38.2% 10Y total return vs AMAT's 20.1%
- 23.7% revenue growth vs TRT's -13.8%
- +282.9% vs NVEC's +52.6%
AMAT is the clearest fit if your priority is valuation efficiency.
- PEG 2.16 vs NVEC's 3.54
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 23.7% revenue growth vs TRT's -13.8% | |
| Value | Lower P/E (18.9x vs 50.7x) | |
| Quality / Margins | 57.7% margin vs TRT's -0.2% | |
| Stability / Safety | Beta 0.52 vs LRCX's 2.54, lower leverage | |
| Dividends | 4.5% yield, 2-year raise streak, vs LRCX's 0.3%, (1 stock pays no dividend) | |
| Momentum (1Y) | +282.9% vs NVEC's +52.6% | |
| Efficiency (ROA) | 31.4% ROA vs TRT's -0.2%, ROIC 55.7% vs 0.8% |
TRT vs NVEC vs RELL vs LRCX vs AMAT — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
TRT vs NVEC vs RELL vs LRCX vs AMAT — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
LRCX leads in 2 of 6 categories
NVEC leads 1 • RELL leads 1 • TRT leads 0 • AMAT leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
NVEC leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
AMAT is the larger business by revenue, generating $28.4B annually — 1077.4x NVEC's $26M. NVEC is the more profitable business, keeping 57.7% of every revenue dollar as net income compared to TRT's -0.2%. On growth, TRT holds the edge at +81.6% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $49M | $26M | $213M | $21.7B | $28.4B |
| EBITDAEarnings before interest/tax | $3M | $16M | $8M | $7.8B | $8.4B |
| Net IncomeAfter-tax profit | -$109,000 | $15M | $806,000 | $6.7B | $7.0B |
| Free Cash FlowCash after capex | $137,000 | $14M | $2M | $6.5B | $5.7B |
| Gross MarginGross profit ÷ Revenue | +19.7% | +78.7% | +31.1% | +50.0% | +48.7% |
| Operating MarginEBIT ÷ Revenue | +0.5% | +60.5% | +1.8% | +34.3% | +29.2% |
| Net MarginNet income ÷ Revenue | -0.2% | +57.7% | +0.4% | +30.9% | +24.7% |
| FCF MarginFCF ÷ Revenue | +0.3% | +54.9% | +0.9% | +29.8% | +20.1% |
| Rev. Growth (YoY)Latest quarter vs prior year | +81.6% | +5.3% | +5.7% | +23.8% | -3.5% |
| EPS Growth (YoY)Latest quarter vs prior year | -76.0% | +27.5% | +79.2% | +40.8% | +13.9% |
Valuation Metrics
RELL leads this category, winning 3 of 7 comparable metrics.
Valuation Metrics
At 28.2x trailing earnings, NVEC trades at a 59% valuation discount to LRCX's 69.0x P/E. Adjusting for growth (PEG ratio), AMAT offers better value at 2.76x vs NVEC's 5.28x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $101M | $429M | $183M | $357.7B | $325.5B |
| Enterprise ValueMkt cap + debt − cash | $92M | $428M | $149M | $356.0B | $324.9B |
| Trailing P/EPrice ÷ TTM EPS | -2416.67x | 28.21x | -159.96x | 69.01x | 47.40x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 18.93x | 58.27x | 50.65x | 37.07x |
| PEG RatioP/E ÷ EPS growth rate | — | 5.28x | — | 3.08x | 2.76x |
| EV / EBITDAEnterprise value multiple | 30.78x | 26.86x | 96.90x | 56.63x | 38.68x |
| Price / SalesMarket cap ÷ Revenue | 2.78x | 16.27x | 0.87x | 19.40x | 11.48x |
| Price / BookPrice ÷ Book value/share | 2.98x | 7.36x | 1.17x | 37.47x | 16.25x |
| Price / FCFMarket cap ÷ FCF | — | 29.62x | 23.61x | 66.06x | 57.13x |
Profitability & Efficiency
LRCX leads this category, winning 7 of 9 comparable metrics.
Profitability & Efficiency
LRCX delivers a 65.8% return on equity — every $100 of shareholder capital generates $66 in annual profit, vs $-0 for TRT. NVEC carries lower financial leverage with a 0.01x debt-to-equity ratio, signaling a more conservative balance sheet compared to LRCX's 0.48x. On the Piotroski fundamental quality scale (0–9), LRCX scores 8/9 vs TRT's 4/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -0.3% | +25.6% | +0.5% | +65.8% | +34.3% |
| ROA (TTM)Return on assets | -0.2% | +24.8% | +0.4% | +31.4% | +19.3% |
| ROICReturn on invested capital | +0.8% | +21.2% | -1.4% | +55.7% | +33.3% |
| ROCEReturn on capital employed | +0.7% | +26.0% | -1.5% | +40.4% | +30.6% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 6 | 6 | 8 | 7 |
| Debt / EquityFinancial leverage | 0.05x | 0.01x | 0.01x | 0.48x | 0.32x |
| Net DebtTotal debt minus cash | -$9M | -$973,617 | -$34M | -$1.6B | -$686M |
| Cash & Equiv.Liquid assets | $11M | $2M | $36M | $6.4B | $7.2B |
| Total DebtShort + long-term debt | $2M | $740,423 | $2M | $4.8B | $6.6B |
| Interest CoverageEBIT ÷ Interest expense | 0.57x | — | — | 58.92x | 35.46x |
Total Returns (Dividends Reinvested)
LRCX leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in LRCX five years ago would be worth $46,048 today (with dividends reinvested), compared to $13,865 for NVEC. Over the past 12 months, LRCX leads with a +282.9% total return vs NVEC's +52.6%. The 3-year compound annual growth rate (CAGR) favors LRCX at 76.4% vs RELL's 0.0% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -6.8% | +45.8% | +38.7% | +54.9% | +52.9% |
| 1-Year ReturnPast 12 months | +121.8% | +52.6% | +71.8% | +282.9% | +164.7% |
| 3-Year ReturnCumulative with dividends | +169.5% | +13.0% | +0.1% | +448.8% | +258.7% |
| 5-Year ReturnCumulative with dividends | +124.8% | +38.6% | +114.2% | +360.5% | +213.8% |
| 10-Year ReturnCumulative with dividends | +248.3% | +124.0% | +228.9% | +3815.1% | +2014.4% |
| CAGR (3Y)Annualised 3-year return | +39.2% | +4.2% | +0.0% | +76.4% | +53.1% |
Risk & Volatility
Evenly matched — TRT and NVEC each lead in 1 of 2 comparable metrics.
Risk & Volatility
TRT is the less volatile stock with a 0.52 beta — it tends to amplify market swings less than LRCX's 2.54 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. NVEC currently trades 98.4% from its 52-week high vs TRT's 60.7% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.52x | 1.58x | 2.02x | 2.54x | 2.14x |
| 52-Week HighHighest price in past year | $19.10 | $90.00 | $15.34 | $298.00 | $432.81 |
| 52-Week LowLowest price in past year | $4.42 | $57.21 | $8.66 | $72.91 | $151.51 |
| % of 52W HighCurrent price vs 52-week peak | +60.7% | +98.4% | +96.9% | +96.1% | +94.8% |
| RSI (14)Momentum oscillator 0–100 | 58.4 | 63.8 | 67.4 | 69.9 | 66.3 |
| Avg Volume (50D)Average daily shares traded | 1.0M | 53K | 109K | 9.7M | 6.0M |
Analyst Outlook
Evenly matched — NVEC and LRCX each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: RELL as "Hold", LRCX as "Buy", AMAT as "Buy". Consensus price targets imply 3.9% upside for AMAT (target: $426) vs -5.8% for RELL (target: $14). For income investors, NVEC offers the higher dividend yield at 4.51% vs LRCX's 0.31%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | — | Hold | Buy | Buy |
| Price TargetConsensus 12-month target | — | — | $14.00 | $290.65 | $426.39 |
| # AnalystsCovering analysts | — | — | 1 | 50 | 53 |
| Dividend YieldAnnual dividend ÷ price | — | +4.5% | +1.9% | +0.3% | +0.4% |
| Dividend StreakConsecutive years of raises | 0 | 2 | 2 | 11 | 8 |
| Dividend / ShareAnnual DPS | — | $4.00 | $0.28 | $0.89 | $1.71 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% | 0.0% | +1.0% | +1.5% |
LRCX leads in 2 of 6 categories (Profitability & Efficiency, Total Returns). NVEC leads in 1 (Income & Cash Flow). 2 tied.
TRT vs NVEC vs RELL vs LRCX vs AMAT: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is TRT or NVEC or RELL or LRCX or AMAT a better buy right now?
For growth investors, Lam Research Corporation (LRCX) is the stronger pick with 23.
7% revenue growth year-over-year, versus -13. 8% for Trio-Tech International (TRT). NVE Corporation (NVEC) offers the better valuation at 28. 2x trailing P/E (18. 9x forward), making it the more compelling value choice. Analysts rate Lam Research Corporation (LRCX) a "Buy" — based on 50 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — TRT or NVEC or RELL or LRCX or AMAT?
On trailing P/E, NVE Corporation (NVEC) is the cheapest at 28.
2x versus Lam Research Corporation at 69. 0x. On forward P/E, NVE Corporation is actually cheaper at 18. 9x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Applied Materials, Inc. wins at 2. 16x versus NVE Corporation's 3. 54x.
03Which is the better long-term investment — TRT or NVEC or RELL or LRCX or AMAT?
Over the past 5 years, Lam Research Corporation (LRCX) delivered a total return of +360.
5%, compared to +38. 6% for NVE Corporation (NVEC). Over 10 years, the gap is even starker: LRCX returned +38. 2% versus NVEC's +124. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — TRT or NVEC or RELL or LRCX or AMAT?
By beta (market sensitivity over 5 years), Trio-Tech International (TRT) is the lower-risk stock at 0.
52β versus Lam Research Corporation's 2. 54β — meaning LRCX is approximately 386% more volatile than TRT relative to the S&P 500. On balance sheet safety, NVE Corporation (NVEC) carries a lower debt/equity ratio of 1% versus 48% for Lam Research Corporation — giving it more financial flexibility in a downturn.
05Which is growing faster — TRT or NVEC or RELL or LRCX or AMAT?
By revenue growth (latest reported year), Lam Research Corporation (LRCX) is pulling ahead at 23.
7% versus -13. 8% for Trio-Tech International (TRT). On earnings-per-share growth, the picture is similar: Lam Research Corporation grew EPS 43. 1% year-over-year, compared to -104. 0% for Trio-Tech International. Over a 3-year CAGR, AMAT leads at 3. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — TRT or NVEC or RELL or LRCX or AMAT?
NVE Corporation (NVEC) is the more profitable company, earning 57.
7% net margin versus -0. 5% for Richardson Electronics, Ltd. — meaning it keeps 57. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: NVEC leads at 60. 5% versus -1. 2% for RELL. At the gross margin level — before operating expenses — NVEC leads at 78. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is TRT or NVEC or RELL or LRCX or AMAT more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Applied Materials, Inc. (AMAT) is the more undervalued stock at a PEG of 2. 16x versus NVE Corporation's 3. 54x. Both stocks trade at elevated growth-adjusted valuations, so expected growth needs to materialise. On forward earnings alone, NVE Corporation (NVEC) trades at 18. 9x forward P/E versus 58. 3x for Richardson Electronics, Ltd. — 39. 3x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for AMAT: 3. 9% to $426. 39.
08Which pays a better dividend — TRT or NVEC or RELL or LRCX or AMAT?
In this comparison, NVEC (4.
5% yield), RELL (1. 9% yield), AMAT (0. 4% yield), LRCX (0. 3% yield) pay a dividend. TRT does not pay a meaningful dividend and should not be held primarily for income.
09Is TRT or NVEC or RELL or LRCX or AMAT better for a retirement portfolio?
For long-horizon retirement investors, Trio-Tech International (TRT) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
52), +248. 3% 10Y return). Applied Materials, Inc. (AMAT) carries a higher beta of 2. 14 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (TRT: +248. 3%, AMAT: +20. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between TRT and NVEC and RELL and LRCX and AMAT?
Both stocks operate in the Technology sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: TRT is a small-cap quality compounder stock; NVEC is a small-cap income-oriented stock; RELL is a small-cap quality compounder stock; LRCX is a large-cap high-growth stock; AMAT is a large-cap quality compounder stock. NVEC, RELL pay a dividend while TRT, LRCX, AMAT do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.